Analyse and tell if the 'Product Launch' for CDF is approved based on below inputs:


APPROVAL STEP 1: BUSINESS CASE PREPARATION & Country Pricing Strategy

Primary Research for Pricing strategy: COMPLETED
Price Points, HCP trialist, Affordable patients, patient share, No of patients. Is above step 'Primary Research for Pricing strategy' is also COMPLETED: COMPLETED. 

Country level: APPROVED
Region level:  NOT APPROVED
Global level:  APPROVED


APPROVAL STEP 2: HA - COUNTRY HEALTH AUTHORITY APPROVAL

Phase III trial: 	COMPLETED
APPROVAL from EU/USFDA: COMPLETED
Medical Rationale - is Unmet need is specified, value proposition of the molecule is stated and APPROVED by Country Medical Officer: COMPLETED 
Site registration - Manufacturing unit from Germany set up/ process are done: COMPLETED
Dosier creation - when the above steps are also COMPLETED - Medical rationale, Phase III trial, unmet need, approval by EU/USFDA: NOT COMPLETED
SEC meeting with HA HCPs should approve molecule proposal with medical rationale.: APPROVED
Phase IV trial required in case India patients are not there in phase III trial USFDA & EU approval for molecule.: REQUIRED if India patients are not there in phase III trial USFDA & EU approval else NOT-REQUIRED.



APPROVAL STEP 3: Packaging

Country level: NOT APPROVED
Region level: APPROVED
Global level: APPROVED



APPROVAL STEP 4: Supply & Chain

Stock availability India C&F: NOT COMPLETED
Stockist/Site registration: COMPLETED
Transit to local stockist: COMPLETED
Payment by stockist/C&F: NOT COMPLETED


APPROVAL STEP 5: Prelaunch ( Parallel Step)

Primary Research: Understand Adoption ladder: NOT COMPLETED
Understanding patient funnel: COMPLETED
Unaided awareness for therapy & molecule: COMPLETED
Market potential: State/city wise: COMPLETED
MSL deployment: COMPLETED
MSL list: COMPLETED
FF recruitment: COMPLETED
Training & development: COMPLETED
Prelaunch Initiatives: Teasers of DSA: COMPLETED

